AMY MASON: Open Payments
NPI 1215661376 · MUSTANG, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 29 payments from 17 companies in 2025. Trend: 2023 $662 · 2024 $907 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 2 | $66 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Corcept Therapeutics | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Almatica Pharma LLC | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $30 |
Products named: WAKIX, Korlym, Auvelity, LOREEV XR, COBENFY, XIFAXAN, REXULTI, GEMTESA.
Industry payments across OK — which companies pay providers there.
